Abstract:Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease characterized by airflow limitation and changes in airway structures that can lead to chronic bronchitis, small airway diseases, and emphysema. COPD is the 3rd leading cause of death worldwide and despite current research, there are no curative disease treatments for COPD. As the prevalence of COPD is higher in people over 60 years old than in younger age groups, COPD is considered a condition of accelerated lung aging. Natural lung aging is associated with molecular, cellular, and physiological changes that cause alteration in lung structure, in lung function and regeneration, and decreased immune system response that could lead to lung disease like COPD. Mechanisms of accelerated lung aging are complex and composed by increased oxidative stress induced by exposure to cigarette smoke, by chronic inflammatory processes, and increased number of senescent cells within the airways. Cellular senescence is the cessation of cell division after a finite number of proliferation cycles or in response to cell stressors, such as oxidative stress. Senescent cells show activation of the cell cycle regulators p21CIP1 (cyclin-dependent kinase inhibitor-1), p16INK4 (cyclin-dependent kinase inhibitor-2A), and p53 (cellular tumor antigen p53) that lead to cell cycle arrest. Senescent cells exhibit a change in their phenotype and their metabolic activity, along with the production of proinflammatory proteins collectively known as senescence-associated secretory phenotype (SASP). This review aims to describe recent developments in our understanding of aging mechanisms and how the acceleration of lung aging participates in COPD pathophysiology and comorbidities. Understanding and targeting aging mechanisms may result in the development of new therapeutics that could be effective for COPD and also for other age-related diseases.

Impact of aging on immune function in the pathogenesis of pulmonary diseases: potential for therapeutic targets

Aging Immune System and Its Correlation with Liability to Severe Lung Complications.

Aging and Susceptibility to Pulmonary Disease.

Cellular senescence is a key mediator of lung aging and susceptibility to infection

Aging Lung: Molecular Drivers and Impact on Respiratory Diseases—A Narrative Clinical Review

Immune aging: biological mechanisms, clinical symptoms, and management in lung transplant recipients

Respiratory Infections in the Aging Lung: Implications for Diagnosis, Therapy, and Prevention

Unveiling mechanisms of lung aging in COPD: A promising target for therapeutics development

Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19

The aging lung: microenvironment, mechanisms, and diseases

The Impact of Immune System Aging on Infectious Diseases

Immunosenescence, Inflammaging, and Lung Senescence in Asthma in the Elderly

The Aging Microenvironment in Lung Fibrosis

Immune Alterations with Aging: Mechanisms and Intervention Strategies

Hallmarks of aging and immunosenescence: Connecting the dots

Aging and Immune Function: Molecular Mechanisms to Interventions

Patho-Physiology of Aging and Immune-Senescence: Possible Correlates With Comorbidity and Mortality in Middle-Aged and Old COVID-19 Patients

Pulmonary Health and Healthy Aging

[Research Progress of Lung Aging in Chronic Respiratory Diseases].

The ageing immune system as a potential target of senolytics

Aging, inflammaging and immunosenescence as risk factors of severe COVID-19